Total Payments
$27,149
2024 Payments
$2,405
Companies
78
Transactions
2,018
Medicare Patients
6,859
Medicare Billing
$440,764
Payment Breakdown by Category
Food & Beverage$26,921 (99.2%)
Education$228.07 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,921 | 2,000 | 99.2% |
| Education | $228.07 | 18 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,116 | 305 | $0 (2024) |
| Lilly USA, LLC | $2,488 | 176 | $0 (2024) |
| ABBVIE INC. | $2,252 | 165 | $0 (2024) |
| PFIZER INC. | $1,664 | 159 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,594 | 96 | $0 (2024) |
| Amgen Inc. | $1,365 | 86 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,162 | 88 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $714.41 | 46 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $711.84 | 58 | $0 (2021) |
| Amarin Pharma Inc. | $663.97 | 43 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,405 | 142 | Lilly USA, LLC ($585.04) |
| 2023 | $3,215 | 190 | ABBVIE INC. ($744.92) |
| 2022 | $3,952 | 265 | ABBVIE INC. ($570.57) |
| 2021 | $3,634 | 276 | AbbVie Inc. ($577.71) |
| 2020 | $2,964 | 227 | Novo Nordisk Inc ($529.80) |
| 2019 | $2,996 | 229 | Novo Nordisk Inc ($302.61) |
| 2018 | $3,595 | 300 | Novo Nordisk Inc ($393.07) |
| 2017 | $4,388 | 389 | Novo Nordisk Inc ($496.25) |
All Payment Transactions
2,018 individual payment records from CMS Open Payments — Page 1 of 81
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: VACCINES | ||||||
| 12/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Insomnia | ||||||
| 12/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Biological | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Obesity | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: ORTHOPEDICS | ||||||
| 11/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/31/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/29/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Insomnia | ||||||
| 10/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Biological | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.39 | General |
| 10/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,641 | 2,581 | $247,802 | $106,288 |
| 2022 | 26 | 1,550 | 2,566 | $233,080 | $114,314 |
| 2021 | 25 | 1,658 | 2,735 | $231,141 | $116,645 |
| 2020 | 25 | 2,010 | 3,713 | $238,677 | $103,517 |
Total Patients
6,859
Total Services
11,595
Medicare Billing
$440,764
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 190 | 534 | $84,055 | $33,235 | 39.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 175 | 175 | $48,125 | $22,713 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 226 | $47,150 | $19,769 | 41.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 129 | 129 | $16,125 | $8,256 | 51.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 20 | $7,125 | $4,436 | 62.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 170 | 170 | $6,120 | $3,128 | 51.1% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 99 | 99 | $4,950 | $2,615 | 52.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 86 | 242 | $9,680 | $2,561 | 26.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $3,300 | $1,964 | 59.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 70 | 71 | $3,763 | $1,852 | 49.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $1,680 | $1,313 | 78.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 44 | 44 | $2,420 | $924.24 | 38.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 17 | $2,040 | $709.75 | 34.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 34 | 54 | $2,160 | $644.80 | 29.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 161 | 172 | $1,204 | $586.52 | 48.7% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 22 | 36 | $900.00 | $334.63 | 37.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 31 | $1,302 | $327.42 | 25.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 55 | 57 | $1,140 | $317.81 | 27.9% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 36 | 59 | $885.00 | $248.40 | 28.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 20 | 29 | $580.00 | $150.39 | 25.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 45 | 94 | $940.00 | $102.46 | 10.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 28 | 174 | $1,218 | $67.85 | 5.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 19 | 94 | $940.00 | $33.41 | 3.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 207 | 579 | $71,040 | $35,545 | 50.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 175 | 175 | $48,125 | $23,425 | 48.7% |
About Dr. Benedict Go, MD
Dr. Benedict Go, MD is a Internal Medicine healthcare provider based in Riverview, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831147768.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benedict Go, MD has received a total of $27,149 in payments from pharmaceutical and medical device companies, with $2,405 received in 2024. These payments were reported across 2,018 transactions from 78 companies. The most common payment nature is "Food and Beverage" ($26,921).
As a Medicare-enrolled provider, Go has provided services to 6,859 Medicare beneficiaries, totaling 11,595 services with total Medicare billing of $440,764. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Riverview, MI
- Active Since 05/04/2006
- Last Updated 10/10/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1831147768
Products in Payments
- VRAYLAR (Drug) $1,370
- FARXIGA (Drug) $1,100
- Ozempic (Drug) $930.06
- JARDIANCE (Drug) $886.58
- Saxenda (Drug) $886.48
- XIFAXAN (Drug) $768.40
- UBRELVY (Drug) $750.41
- Vascepa (Drug) $663.97
- EVENITY (Biological) $643.95
- CONTRAVE (Drug) $589.22
- CHANTIX (Drug) $530.88
- MOUNJARO (Drug) $520.15
- EMGALITY (Drug) $515.83
- TRULICITY (Drug) $491.59
- Kerendia (Drug) $471.16
- ELIQUIS (Drug) $469.82
- YUPELRI (Drug) $467.49
- JANUVIA (Drug) $459.19
- NURTEC ODT (Drug) $448.22
- Victoza (Drug) $433.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Riverview
Orlando Portal, M.d, M.D
Internal Medicine — Payments: $237,427
Internal Medicine $237,427
Dr. Khalid Mohammed, Do, DO
Internal Medicine — Payments: $24,106
Internal Medicine $24,106
Mrs. Sara Regino, Msn, Aprn, Agpcnp-Bc, MSN, APRN, AGPCNP-BC
Internal Medicine — Payments: $11,772
Internal Medicine $11,772
Khaldia Khaled
Internal Medicine — Payments: $11,645
Internal Medicine $11,645
Margaret Colleran, M.d, M.D
Internal Medicine — Payments: $10,465
Internal Medicine $10,465
Dr. Michaele Oostendorp, Do, DO
Internal Medicine — Payments: $9,104
Internal Medicine $9,104